Clinical Trials in Nashville

Showing 18181-18200 of 20,298 trials

Pancreatic Cancer Serum and DNA Repository

NCT00296114

To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:

Pancreas Cancer

Pancreatic Cancer Research Team690 participantsStarted Feb 2004

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +7 more locations

UNKNOWNPhase 1/2< 1 mile

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

NCT01670513

Subjects with a clinical diagnosis of plaque psoriasis with 10% to 20% of body surface area affected will be enrolled in the study.

Plaque Psoriasis

Dow Pharmaceutical Sciences60 participantsStarted Jun 2012

Santa Rosa, California, United States • Clinton Township, Michigan, United States • Fort Gratiot, Michigan, United States +3 more locations

Pancreatic Cancer Serum and DNA Repository

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Find Trials by Condition in Nashville

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Care Transitions in Renal Disease Patients

A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Treatment of Moderate to Severe Facial Acne Vulgaris

Advisa MRI Clinical Study

Drug Eluting Stent Registry of Thrombosis

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Doxycycline and OA Progression

Azithromycin/Bicillin Syphilis

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting

SoundBite Hearing System 24 Month Multi Site Patient Use Study

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations